Irreversible imatinib-induced pneumonitis following long-term imatinib administration

Internal Medicine

Volumn 46, Issue 23, 2007, Pages 1941-1942

  Seki, Nobuhiko ^a   Ito, Akemi ^a   Watanabe, Kennichi ^a   Shibakuku, Reishi ^a   Seto, Takashi ^a   Uematsu, Kazutsugu ^a   Mine, Tetsuya ^a   Eguchi, Kenji ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Imatinib induced pneumonitis; Long tern administration

Indexed keywords

IMATINIB;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DRUG WITHDRAWAL; DYSPNEA; GASTROINTESTINAL STROMAL TUMOR; HUMAN; IMAGE ANALYSIS; INTERSTITIAL PNEUMONIA; LONG TERM CARE; MALE; METASTASIS; THORAX RADIOGRAPHY; TUMOR REGRESSION;

AGED; ANTINEOPLASTIC AGENTS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; PIPERAZINES; PYRIMIDINES;

EID: 37549010988     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0542     Document Type: Article

References (4)

1. Bergeron A, Bergot E, Vilela G, et al. Hypersensitivity pneumonitis related to imatinib mesylate. J Clin Oncol 20: 4271-4272, 2002.
2. Rosado MF, Donna E, Ahn YS. Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis. J Clin Oncol 21: 3171-3173, 2003.
3. Ma CX, Hobday TJ, Jett JR. Imatinib mesylate-induced interstitial pneumonitis. Mayo Clin Proc 78: 1578-1579, 2003.
4. Ohnishi K, Sakai F, Kudoh S, Ohno R. Twenty-seven cases of drug-induced interstitial lung disease associated with imatinib mesylate. Leukemia 20: 1162-1164, 2006.